Skip to main content
. 2023 Jan 31;29(12):1886–1894. doi: 10.1093/ibd/izad001

Table 1.

Clinical and demographic characteristics of the study population (n = 190).

Women (n = 88) Men (n = 102) P
Median age, years (IQR) 41.5 (27.2-52.7) 45 (30.7-58.2) 0.232
Disease type
  CD 53 (60.2) 47 (46.1)
  UC 35 (39.8) 55 (53.9) 0.051
Disease duration, months (IQR) 4.4 (3.1-5.9) 4.5 (3.2-5.9) 0.757
Median BMI, kg/m2 (IQR) 22.7 (20.1-26.1) 25.1 (22.4-28.2) 0.001*
Tobacco use
   Smoker 20 (22.7) 18 (17.6) 0.031*
   Former smoker 25 (28.4) 48 (47.1)
   Non-smoker 43 (48.9) 36 (35.3)
Marital status
  Married/partner 51 (58) 60 (58.8) 0.904
  Single/divorced/widowed 37 (42) 42 (41.2)
Education
  Low level 62 (70.5) 71 (69.6) 0.899
  High level 26 (29.5) 31 (30.4)
Active employment 38 (43.2) 61 (59.8) 0.022*
Comorbidity 43 (48.9) 41 (40.2) 0.230
Previous history of MAD 16 (18.2) 2 (2) < 0.001*
CD Montreal classification
Age group
 A2: 17–40 years 24 (45.3) 24 (51.1) 0.564
 A3: ≥40 years 29 (54.7) 23 (48.9)
Location of Crohn’s (>1 location possible)
 L1: Ileal 26 (49.1) 29 (61.7) 0.205
 L2: Colonic 10 (18.9) 5 (10.6) 0.250
 L3: Ileocolonic 17 (32.1) 12 (25.5) 0.472
 L4: Upper GI 3 (5.7) 3 (6.4) 1
Crohn’s behavior
 B1: Inflammatory 40 (75.5) 35 (74.5) 0.959
 B2: Stricturing 8 (15.1) 8 (17)
 B3: Penetrating 5 (9.4) 4 (8.5)
Perianal involvement 5 (9.4) 2 (4.3) 0.311
UC Montreal classification
 E1: Proctitis 13 (37.1) 11 (20) 0.198
 E2: Left-sided colitis 13 (37.1) 25 (45.5)
 E3: Extensive colitis 9 (25.7) 19 (34.5)
IBD activity
  Mild 40 (45.5) 44 (43.1) 0.748
  Moderate/severe 48 (54.5) 58 (56.9)
Median CRP, mg/L (IQR) 11 (2.4-58.8) 6.6 (1.9-34.5) 0.149
Median fecal calprotectin, μg/g (IQR) 602 (122-1994) 532 (94.2-1320) 0.422
Anemia 34 (38.6) 25 (24.5) 0.036*
EIM 14 (15.9) 7 (6.9) 0.047*
Family history of IBD 26 (29.5) 16 (15.7) 0.022*

Values are n (%) unless otherwise noted. Abbreviations: CD, Crohn’s disease; UC, ulcerative colitis; IBD, inflammatory bowel disease; BMI, body mass index; MAD, mood and/or anxiety disorders; CRP, C-reactive protein; EIM, extra-intestinal manifestations; IQR, interquartile range.

*statistically significant at P < .05.